Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol - PubMed
- ️Sun Jan 01 2012
Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol
Valerie M Kramlinger et al. Chem Biol Interact. 2012.
Abstract
Nicotine is the primary addictive agent in tobacco products and is metabolized in humans by CYP2A6. Decreased CYP2A6 activity has been associated with decreased smoking. The extrahepatic enzyme, CYP2A13 (94% identical to CYP2A6) also catalyzes the metabolism of nicotine, but is most noted for its role in the metabolic activation of the tobacco specific lung carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). In this study, the inhibition and potential inactivation of CYP2A6 and CYP2A13 by two tobacco constituents, 1-methyl-4-(3-pyridinyl) pyrrole (β-nicotyrine) and (-)-menthol were characterized and compared to the potent mechanism based inactivator of CYP2A6, menthofuran. The effect of these compounds on CYP2A6 and CYP2A13 activity was significantly different. (-)-Menthol was a more efficient inhibitor of CYP2A13 than of CYP2A6 (KI, 8.2 μM and 110 μM, respectively). β-Nicotyrine was a potent inhibitor of CYP2A13 (KI, 0.17 μM). Neither menthol nor β-nicotyrine was an inactivator of CYP2A13. Whereas, β-nicotyrine was a mechanism based inactivator of CYP2A6 (KI(inact), 106 μM, kinact was 0.61 min(-1)). Similarly, menthofuran, a potent mechanism based inactivator of CYP2A6 did not inactivate CYP2A13. Menthofuran was an inhibitor of CYPA13 (KI, 1.24 μM). The inactivation of CYP2A6 by either β-nicotyrine or menthofuran was not due to modification of the heme and was likely due to modification of the apo-protein. These studies suggest that β-nicotyrine, but not menthol may influence nicotine and NNK metabolism in smokers.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
Conflict of Interest
The authors declare no financial or commercial conflict of interest.
Figures

Structures of nicotine, β-nicotyrine, (−)- menthol, and menthofuran.

Activity remaining refers to coumarin 7-hydroxylation activity determined in a secondary reaction. Details of the experiments are as described in Materials and Methods. The menthofuran concentrations used were 0(●), 1(○), 2.5(▼), 5(▽) and 10(■) μM and the β-nicotyrine concentrations used were 0(●), 5(○), 10(▼), 40(▽) and 80(■) μM. Values are the mean ± S.D. from three independent experiments. The insets represent the double-reciprocal plot generated from the slopes of the lines at the various concentrations.

The inactivation was allowed to go to completion, and then coumarin 7-hydroxylation activity was determined in a secondary reaction as described under Materials and Methods. Values are the mean ± S.D. of three independent experiments performed in duplicate. The arrow indicates the intercept used to determine the partition ratio.
Similar articles
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
Salisbury L, Baraitser L. Salisbury L, et al. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
CYP2A6 polymorphisms and risk for tobacco-related cancers.
Rossini A, de Almeida Simão T, Albano RM, Pinto LF. Rossini A, et al. Pharmacogenomics. 2008 Nov;9(11):1737-52. doi: 10.2217/14622416.9.11.1737. Pharmacogenomics. 2008. PMID: 19018727 Review.
-
The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs.
Gao Y, Miksys S, Palmour RM, Tyndale RF. Gao Y, et al. Mol Pharmacol. 2020 Dec;98(6):658-668. doi: 10.1124/molpharm.120.000100. Epub 2020 Oct 14. Mol Pharmacol. 2020. PMID: 33055223
-
Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL, Murphy SE, Wilkens LR, Stram DO, Hecht SS, Le Marchand L. Park SL, et al. PLoS One. 2017 May 25;12(5):e0178435. doi: 10.1371/journal.pone.0178435. eCollection 2017. PLoS One. 2017. PMID: 28542511 Free PMC article.
Cited by
-
Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.
Vrzal R. Vrzal R. Int J Mol Sci. 2021 Nov 14;22(22):12306. doi: 10.3390/ijms222212306. Int J Mol Sci. 2021. PMID: 34830188 Free PMC article. Review.
-
Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice.
Alsharari SD, King JR, Nordman JC, Muldoon PP, Jackson A, Zhu AZ, Tyndale RF, Kabbani N, Damaj MI. Alsharari SD, et al. PLoS One. 2015 Sep 10;10(9):e0137070. doi: 10.1371/journal.pone.0137070. eCollection 2015. PLoS One. 2015. PMID: 26355604 Free PMC article.
-
Reactive metabolites in the biotransformation of molecules containing a furan ring.
Peterson LA. Peterson LA. Chem Res Toxicol. 2013 Jan 18;26(1):6-25. doi: 10.1021/tx3003824. Epub 2012 Oct 24. Chem Res Toxicol. 2013. PMID: 23061605 Free PMC article. Review.
-
Tzoupis H, Papavasileiou KD, Papatzelos S, Mavrogiorgis A, Zacharia LC, Melagraki G, Afantitis A. Tzoupis H, et al. Int J Mol Sci. 2024 Jul 23;25(15):8031. doi: 10.3390/ijms25158031. Int J Mol Sci. 2024. PMID: 39125600 Free PMC article.
-
Goyal N, Sridhar J, Do C, Bratton M, Shaik S, Jiang Q, Foroozesh M. Goyal N, et al. J Cancer Metastasis Treat. 2021;7:18. doi: 10.20517/2394-4722.2020.143. Epub 2021 Apr 14. J Cancer Metastasis Treat. 2021. PMID: 34722929 Free PMC article.
References
-
- Benowitz NL. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318–1330. - PubMed
-
- Benowitz NL, Herrera B, Jacob P., III Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004;310:1208–1215. - PubMed
-
- MacDougall JM, Fandrick K, Zhang X, Serafin SV, Cashman JR. Inhibition of human liver microsomal (S)-nicotine oxidation by (−)-menthol and analogues. Chem Res Toxicol. 2003;16:988–993. - PubMed
-
- Goozner M. FDA Finding May Curb Mentholated Cigarette Availability. J Natl Cancer Inst. 2011 Apr 7; Epub ahead of print 2011. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous